Primavera Capital Group has closed its third China fund at $3.4 billion, having extended the fundraising period by six months.
The final close – against a target of $2.8 billion – was confirmed by a source familiar with the situation. It follows a first close of $1.5 billion in May 2018. Primavera declined to comment on fundraising....
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Kurt Bjorklund, a co-managing partner at Permira, explains how a sector-focused investment style is becoming indispensable in Asia’s competitive and disruption-prone markets
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Food delivery start-up Delivery Hero has agreed to acquire Korean peer Woowa Brothers in a deal that values the target at $4 billion and will facilitate exits for several private equity investors.